- Global Pharma News & Resources

Blood Culture Test Market exhibiting CAGR of 9.3% by 2032, owing to high incidence of blood stream infections | insightSLICE

The global Blood Culture Test market size was estimated to be US$ 4.21 billion in 2021 and is expected grow at a CAGR of 9.3% between 2023 to 2032.

According to estimates from 2019, bloodstream infections, which afflict 30 million people, cause 6 million deaths annually. To stop further pathogen-related consequences, it is crucial to detect blood infections as soon as possible.

As bacterial infections are the primary cause of most blood infections, their diagnosis is essential for determining the prognosis of the illness. Blood infections have the potential to be lethal when the body’s immune system responds to a pathogen by injuring its tissues.

Access the sample report:

Global Blood Culture Test Market Key Segments:

By Method Type

  • Conventional
  • Automated

By Product

  • Instruments
  • Media
  • Consumables

By Application

  • Bacteremia
  • Fungemia
  • Mycobacterial detection

By End-use

  • Hospitals and Diagnostic Centers
  • Academic Research Laboratories
  • Others

By Geography

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • India
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • South America
    • Brazil
    • Rest of South America

Doctors use blood culture testing to determine the type of infection that is currently present in the bloodstream. Broad-spectrum intravenous antibiotics are now available for doctors to prescribe to their patients due to their capacity to fight a range of microorganisms. Because blood infections represent a major risk to patient health, doctors use automated blood culture testing to quickly acquire accurate results. These factors are also projected to hasten the market expansion for blood culture tests.

The key players of the Global Blood Culture Test Market are:

The following companies are some of the most well-known competitors in the global blood culture testing market: Axiom Laboratories, Anaerobe Systems, Inc., Bulldog Bio, Inc., bioMérieux SA, BINDER GmbH, Bruker Corporation, Biobase Biotech Co., Ltd., Carl Zeiss AG, Danaher Corporation, Dickinson and Company, Luminex Corporation, Meditech Technologies India Private Limited, Nikon Corporation, IRIDICA, and Becton.

Read more about the report inclusions:

Driving factors for the growth of Global Blood Culture Test Market

A rise in bacterial illnesses is primarily caused by evolving lifestyles and rising pollutants. Blood culture tests are becoming more widely used to screen for potential problems as a result of the increasing number of government programs in various nations to assist in early diagnosis. For instance, the Get Ahead of Sepsis campaign was developed by the Centers for Disease Control and Prevention as a public health effort to safeguard Americans against sepsis.

Blood culture tests can help doctors identify infections early on since untreated blood infections can be severe and result in organ failure and even death. Complete body tests have also become more popular as a result of rising healthcare awareness among the populace, which is anticipated to fuel market revenue development.

The economy for blood culture testing is growing due to a number of factors, such as the increasing frequency of infectious diseases, the growing incidence of blood disorders, the growing preference for quick medical testing, the rising percentage of sepsis cases, the high cost of disease control, and the growing elderly population. Due to the increased acceptance rate of novel goods, such as equipment and materials for Bloodstream Infection (BSI) detection, the market for blood culture testing will also have more lucrative and enticing chances.

Additionally, during the forecast period, demand for automated blood culture methods will surpass that for manual methods and exhibit rapid growth rates. Currently, high-income nations are the primary regions where manual processes are being replaced by automated ones.

The desire for automated procedures has increased due to technological advancements, which have improved the accuracy and efficiency of blood culture tests. These automated processes also give clinicians thorough test findings, improving the effectiveness of diagnosis and treatment delivery. Thus, the advancement in automated blood culture test equipment and the rising standard of living will help the market progression.

Request for a customization:

Regional performance of Blood Culture Test Market:

The blood culture test market is dominated by the North American region. The largest concentration of laboratories and places where blood culture testing is used is in this area. Some of the biggest investors in the health care and medical sector include nations like the USA.

The vast availability of blood culture testing for a variety of objectives to significant medical research and development initiatives are primary reasons for the dominance of the USA in this sector. This region is also the most significant hub for healthcare businesses which is expected to sustain the growth of the blood culture test market in the coming years.

The Asia Pacific region is one of the most alluring locations in the modern world for several rising firms to expand. Some of the most densely inhabited countries in this region are particularly vulnerable to common blood-borne diseases and infections. This increased demand has given a growing number of laboratories the ability to do commercial blood culture testing in this area. Rising technological advancements are also encouraging several of the countries in this region to use more advanced diagnostic methods for testing blood cultures.

The yearly growth in sepsis and other BSI cases around the world is motivating many pharmaceutical and diagnostic companies to increase R&D in blood culture tests. Many international businesses in the blood culture and diagnostics sectors are concentrating on APAC countries to set up operations and attract additional funding and investments.

Related reports:

Global Drug Repurposing Market:

Global Preclinical Imaging Market:

Factors hampering the growth of Blood Culture Test:

It is projected that developing, more advanced diagnostic techniques like PCR and PNA-FiSH will overtake culture-based technologies in terms of market share. Greater accuracy in blood culture test findings is encouraged by these new, time-efficient modern technologies. Shortly, these new techniques can have a detrimental effect on the growth and development of the blood culture test business.

The blood culture testing process requires the collection and culturing of blood samples with extreme care and in a sterile environment. Furthermore, the staff involved in peripheral blood collection and culture needs to be trained properly. All these processes involve the employment of highly skilled employees, better infrastructure, and automated technology to increase the possibility of identifying germs.

Shortage of skilled staff and the high cost of culture equipment may cause significant impediments for new and existing laboratories to expand their operations. Such issues are anticipated to hamper the market growth of blood culture tests during the forecast period.

Proceed to purchase:

insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at

Contact us:

Alex R

+1 707 736 6633

Linkedin | Twitter

Editor Details

Last Updated: 08-Nov-2022